search
Back to results

Postural Management for Hip Luxation in Quadriplegic Cerebral Palsy (CPluxprev2020)

Primary Purpose

Quadriplegic Cerebral Palsy

Status
Recruiting
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
postural management
Sponsored by
Azienda Unità Sanitaria Locale Reggio Emilia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Quadriplegic Cerebral Palsy focused on measuring hip luxation

Eligibility Criteria

1 Year - 6 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Cerebral palsy spastic or dyskinetic
  • GMFCS 4 or 5
  • MP<41%
  • Informed Consent acquired

Exclusion Criteria:

  • muscle contracture overcoming defined passive Range Of Motion (ROM)limits
  • anterior hip luxation
  • previous reconstructive hip surgery
  • preventive surgery in previous 12 months
  • lumbar scoliosis >20° Cobb

Sites / Locations

  • Azienda Unità Sanitaria Locale Reggio EmiliaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

sitting position centering femoral heads

Usual postural management

Arm Description

sitting position centering femoral heads according to Lespargot diagram

sitting with the trunk aligned and hips abducted to facilitate activities of daily living

Outcomes

Primary Outcome Measures

Change in Migration Percentage
measure of hip luxation on pelvic radiography

Secondary Outcome Measures

Caregiver Priorities & Child Health Index of Life with Disabilities (CPCHILD)
Parents will fill in a questionnaire about Health Related Quality of Life referred to their child. Minimum value 0, maximum value 100, higher scores mean a better outcome.
Quebec User Evaluation of Satisfaction with Assistive Technology (IT-QUEST)
Parents will fill in a questionnaire measuring their satisfaction about the assistive device ensuring the desired sitting position of their child. Minimum value 1, maximum value 5,higher scores mean a better outcome.
Incidence of pain
Care givers will be interviewed about presence or absence of hip pain in the previous months during personal care and activities of daily living
Assistive devices costs
Costs paid by Health Institution for sitting systems used during the study
Percentage of patients attending Botulinum Toxin-A injections
Botulinum Toxin-A injections in muscles around the hip during the study will be recorded
Percentage of patients attending direct physical treatment
Physiotherapy, other Neuromotor Therapy during the study
Percentage of patients using standing devices in abduction
It will be recorded if the patients will be using standing devices at least 5 hours/week, less than 5 h/week or never
Type of CP (Dyskinetic or spastic)
Type of CP will be recorded to evaluate any association with MP change
Percentage of patients having Intrathecal Baclofen (ITB)
It will be recorded if patients have ITB to evaluate any association with MP change
Percentage of patients taking Baclofen per os
Baclofen oral medication during the study will be recorded
Percentage of patients who underwent Selective Dorsal Rhizotomy (SDR)
It will be recorded if patients underwent SDR in the past to evaluate any association with MP change
Age
Age will be recorded to evaluate any association with MP change
Sex
Sex will be recorded to evaluate any association with MP change
Type of lesion at MRI
Type of lesion at MRI, according to Neonatal Neuroimaging Classification System (maldevelopments | predominant white matter injury | predominant grey matter injury | miscellaneous | Normal). Data will be registered based on previously acquired MRI, considering that the exam is mandatory for the diagnosis of cerebral palsy. It will be recorded to evaluate any association with MP change

Full Information

First Posted
October 1, 2020
Last Updated
November 14, 2022
Sponsor
Azienda Unità Sanitaria Locale Reggio Emilia
Collaborators
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Ospedale IRCCS G. Gaslini di Genova, IRCCS Eugenio Medea, IRCCS Don Carlo Gnocchi di Firenze, Azienda Unita' Sanitaria Locale Di Modena, Azienda Usl di Bologna, Azienda Unità Sanitaria Locale della Romagna, Azienda ULSS di Verona e Provincia, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
search

1. Study Identification

Unique Protocol Identification Number
NCT04603625
Brief Title
Postural Management for Hip Luxation in Quadriplegic Cerebral Palsy
Acronym
CPluxprev2020
Official Title
Postural Management to Prevent Hip Luxation in Quadriplegic Cerebral Palsy Children: Comparing Two Approaches in a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Recruiting
Study Start Date
October 29, 2020 (Actual)
Primary Completion Date
December 31, 2025 (Anticipated)
Study Completion Date
December 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Azienda Unità Sanitaria Locale Reggio Emilia
Collaborators
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Ospedale IRCCS G. Gaslini di Genova, IRCCS Eugenio Medea, IRCCS Don Carlo Gnocchi di Firenze, Azienda Unita' Sanitaria Locale Di Modena, Azienda Usl di Bologna, Azienda Unità Sanitaria Locale della Romagna, Azienda ULSS di Verona e Provincia, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Cerebral palsy (CP) is the most common motor disability in childhood. Among these, hip luxation represents the most frequent and clinically relevant one, affecting 72% of non-ambulatory CP children. Reconstructive surgical treatment is debated in severe CP children, for whom it is crucial to identify an effective preventive approach. The aim of our study is to verify if keeping a sitting position centering femoral heads is more effective than usual postural management (sitting with the trunk aligned and hips abducted), in preventing hip luxation in quadriplegic CP children. It's a multicenter randomized controlled study (13 sites involved). A total of 102 quadriplegic CP children, aged 1-6 years-old, classified as Gross Motor Function Measure System 4 or 5, will be recruited and randomized to usual or experimental sitting, at least 5 hours a day, for 2 years. The primary outcome will be the degree of luxation, measured by means of the Migration Percentage (MP), on pelvic radiography, at 12 and 24 months. Secondary outcomes will include compliance and Health Related-Quality of Life, using validated tools, hip pain, device cost, MRI lesions, concurrent direct neuromotor treatment, use of standing devices and spasticity treatments (botulinum toxin, per os or intrathecal baclofen, selective dorsal rhizotomy). Experimental sitting is expected to reduce the MP change compared to usual care. It will be of interest to compare compliance, QoL and costs in either groups: aspects affecting the effectiveness. Furthermore to evaluate correlations between MP and spasticity treatments, MRI lesion type, and other clinical features.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Quadriplegic Cerebral Palsy
Keywords
hip luxation

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Masking Description
Physicians measuring Migration Percentage (Primary Outcome) will be blind
Allocation
Randomized
Enrollment
102 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
sitting position centering femoral heads
Arm Type
Experimental
Arm Description
sitting position centering femoral heads according to Lespargot diagram
Arm Title
Usual postural management
Arm Type
Active Comparator
Arm Description
sitting with the trunk aligned and hips abducted to facilitate activities of daily living
Intervention Type
Other
Intervention Name(s)
postural management
Intervention Description
postural management in sitting position
Primary Outcome Measure Information:
Title
Change in Migration Percentage
Description
measure of hip luxation on pelvic radiography
Time Frame
Day 0, Month 12, Months 24
Secondary Outcome Measure Information:
Title
Caregiver Priorities & Child Health Index of Life with Disabilities (CPCHILD)
Description
Parents will fill in a questionnaire about Health Related Quality of Life referred to their child. Minimum value 0, maximum value 100, higher scores mean a better outcome.
Time Frame
Day 0, Month 12, Month 24
Title
Quebec User Evaluation of Satisfaction with Assistive Technology (IT-QUEST)
Description
Parents will fill in a questionnaire measuring their satisfaction about the assistive device ensuring the desired sitting position of their child. Minimum value 1, maximum value 5,higher scores mean a better outcome.
Time Frame
Month 12, Month 24
Title
Incidence of pain
Description
Care givers will be interviewed about presence or absence of hip pain in the previous months during personal care and activities of daily living
Time Frame
Day 0, Month 6, Month 12, Month 18, Month 24
Title
Assistive devices costs
Description
Costs paid by Health Institution for sitting systems used during the study
Time Frame
Day 0, Month 6, Month 12, Month 18, Month 24
Title
Percentage of patients attending Botulinum Toxin-A injections
Description
Botulinum Toxin-A injections in muscles around the hip during the study will be recorded
Time Frame
Day 0, Month 6, Month 12, Month 18, Month 24
Title
Percentage of patients attending direct physical treatment
Description
Physiotherapy, other Neuromotor Therapy during the study
Time Frame
Day 0, Month 6, Month 12, Month 18, Month 24
Title
Percentage of patients using standing devices in abduction
Description
It will be recorded if the patients will be using standing devices at least 5 hours/week, less than 5 h/week or never
Time Frame
Day 0, Month 6, Month 12, Month 18, Month 24
Title
Type of CP (Dyskinetic or spastic)
Description
Type of CP will be recorded to evaluate any association with MP change
Time Frame
Day 0
Title
Percentage of patients having Intrathecal Baclofen (ITB)
Description
It will be recorded if patients have ITB to evaluate any association with MP change
Time Frame
Day 0
Title
Percentage of patients taking Baclofen per os
Description
Baclofen oral medication during the study will be recorded
Time Frame
Day 0, Month 6, Month 12, Month 18, Month 24
Title
Percentage of patients who underwent Selective Dorsal Rhizotomy (SDR)
Description
It will be recorded if patients underwent SDR in the past to evaluate any association with MP change
Time Frame
Day 0
Title
Age
Description
Age will be recorded to evaluate any association with MP change
Time Frame
Day 0
Title
Sex
Description
Sex will be recorded to evaluate any association with MP change
Time Frame
Day 0
Title
Type of lesion at MRI
Description
Type of lesion at MRI, according to Neonatal Neuroimaging Classification System (maldevelopments | predominant white matter injury | predominant grey matter injury | miscellaneous | Normal). Data will be registered based on previously acquired MRI, considering that the exam is mandatory for the diagnosis of cerebral palsy. It will be recorded to evaluate any association with MP change
Time Frame
Day 0

10. Eligibility

Sex
All
Minimum Age & Unit of Time
1 Year
Maximum Age & Unit of Time
6 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Cerebral palsy spastic or dyskinetic GMFCS 4 or 5 MP<41% Informed Consent acquired Exclusion Criteria: muscle contracture overcoming defined passive Range Of Motion (ROM)limits anterior hip luxation previous reconstructive hip surgery preventive surgery in previous 12 months lumbar scoliosis >20° Cobb
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
SILVIA FACCIOLI
Phone
+39 0522296208
Email
silvia.faccioli@ausl.re.it
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
SILVIA FACCIOLI
Organizational Affiliation
Azienda Unità Sanitaria Locale Reggio Emilia
Official's Role
Study Chair
Facility Information:
Facility Name
Azienda Unità Sanitaria Locale Reggio Emilia
City
Reggio Emilia
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
silvia faccioli

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
We are going to share results and data at the end of the study by publication
Citations:
PubMed Identifier
24731007
Citation
Bouwhuis CB, van der Heijden-Maessen HC, Boldingh EJ, Bos CF, Lankhorst GJ. Effectiveness of preventive and corrective surgical intervention on hip disorders in severe cerebral palsy: a systematic review. Disabil Rehabil. 2015;37(2):97-105. doi: 10.3109/09638288.2014.908961. Epub 2014 Apr 14.
Results Reference
background
Citation
Dalen Y, Saaf M, Ringertz H, Klefbeck B, Mattsson E, Haglund-Akerlind Y. Effects of standing on bone density and hip dislocation in children with severe cerebral palsy. Adv Physiother,2010;12:187-93.
Results Reference
background
Citation
Diab M, Staheli LT. Ortopedia Pediatrica, 3° ed., Verduci ed., p.65
Results Reference
background
PubMed Identifier
30596451
Citation
Galeoto G, Colucci M, Guarino D, Esposito G, Cosma E, De Santis R, Grifoni G, Valente D, Tofani M. Exploring Validity, Reliability, and Factor Analysis of the Quebec User Evaluation of Satisfaction with Assistive Technology in an Italian Population: A Cross-Sectional Study. Occup Ther Health Care. 2018 Oct;32(4):380-392. doi: 10.1080/07380577.2018.1522682. Epub 2018 Dec 31.
Results Reference
background
PubMed Identifier
30326758
Citation
Hagglund G, Goldring M, Hermanson M, Rodby-Bousquet E. Pelvic obliquity and measurement of hip displacement in children with cerebral palsy. Acta Orthop. 2018 Dec;89(6):652-655. doi: 10.1080/17453674.2018.1519104. Epub 2018 Oct 17.
Results Reference
background
PubMed Identifier
17963501
Citation
Hagglund G, Lauge-Pedersen H, Wagner P. Characteristics of children with hip displacement in cerebral palsy. BMC Musculoskelet Disord. 2007 Oct 26;8:101. doi: 10.1186/1471-2474-8-101.
Results Reference
background
Citation
• Lespargot A. La luxation postéro-externe de la hanche chez l'enfant IMC ou polyhandicapé. Motricité cérébrale,1991;12:37-61
Results Reference
background
PubMed Identifier
31169645
Citation
Lins LAB, Watkins CJ, Shore BJ. Natural History of Spastic Hip Disease. J Pediatr Orthop. 2019 Jul;39(Issue 6, Supplement 1 Suppl 1):S33-S37. doi: 10.1097/BPO.0000000000001347.
Results Reference
background
PubMed Identifier
21552077
Citation
Martinsson C, Himmelmann K. Effect of weight-bearing in abduction and extension on hip stability in children with cerebral palsy. Pediatr Phys Ther. 2011 Summer;23(2):150-7. doi: 10.1097/PEP.0b013e318218efc3.
Results Reference
background
PubMed Identifier
29578990
Citation
Gmelig Meyling C, Ketelaar M, Kuijper MA, Voorman J, Buizer AI. Effects of Postural Management on Hip Migration in Children With Cerebral Palsy: A Systematic Review. Pediatr Phys Ther. 2018 Apr;30(2):82-91. doi: 10.1097/PEP.0000000000000488.
Results Reference
background
PubMed Identifier
28574172
Citation
Miller SD, Juricic M, Hesketh K, Mclean L, Magnuson S, Gasior S, Schaeffer E, O'donnell M, Mulpuri K. Prevention of hip displacement in children with cerebral palsy: a systematic review. Dev Med Child Neurol. 2017 Nov;59(11):1130-1138. doi: 10.1111/dmcn.13480. Epub 2017 Jun 2.
Results Reference
background
PubMed Identifier
16978459
Citation
Narayanan UG, Fehlings D, Weir S, Knights S, Kiran S, Campbell K. Initial development and validation of the Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD). Dev Med Child Neurol. 2006 Oct;48(10):804-12. doi: 10.1017/S0012162206001745.
Results Reference
background
PubMed Identifier
27153480
Citation
Picciolini O, LE Metayer M, Consonni D, Cozzaglio M, Porro M, Gasparroni V, Panou A, Mosca F, Portinaro NM. Can we prevent hip dislocation in children with cerebral palsy? Effects of postural management. Eur J Phys Rehabil Med. 2016 Oct;52(5):682-690. Epub 2016 May 6.
Results Reference
background
PubMed Identifier
31256575
Citation
Sproccati N, Bertana S, Battisti N, Feliciangeli A, Baroncini C, Zenesini C, Cersosimo A. Italian translation and cross-cultural adaptation of the questionnaire for the assessment of quality of life in children with cerebral palsy: Caregiver priorities and Child Health Index of Life with disabilities. Minerva Med. 2021 Oct;112(5):651-653. doi: 10.23736/S0026-4806.19.06072-5. Epub 2019 Jun 25. No abstract available.
Results Reference
background
PubMed Identifier
22881288
Citation
Terjesen T. The natural history of hip development in cerebral palsy. Dev Med Child Neurol. 2012 Oct;54(10):951-7. doi: 10.1111/j.1469-8749.2012.04385.x. Epub 2012 Aug 13.
Results Reference
background
PubMed Identifier
25846730
Citation
Wynter M, Gibson N, Willoughby KL, Love S, Kentish M, Thomason P, Graham HK; National Hip Surveillance Working Group. Australian hip surveillance guidelines for children with cerebral palsy: 5-year review. Dev Med Child Neurol. 2015 Sep;57(9):808-20. doi: 10.1111/dmcn.12754. Epub 2015 Apr 3.
Results Reference
background

Learn more about this trial

Postural Management for Hip Luxation in Quadriplegic Cerebral Palsy

We'll reach out to this number within 24 hrs